December 17, 2017 – By Vivian Park
Bvf Inc increased Achillion Pharmaceuticals Inc (ACHN) stake by 6.23% reported in 2017Q2 SEC filing. Bvf Inc acquired 204,677 shares as Achillion Pharmaceuticals Inc (ACHN)’s stock 0.00%. The Bvf Inc holds 3.49 million shares with $16.02 million value, up from 3.29 million last quarter. Achillion Pharmaceuticals Inc now has $380.49 million valuation. The stock decreased 4.50% or $0.13 during the last trading session, reaching $2.76. About 9.78 million shares traded or 410.59% up from the average. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has declined 47.61% since December 17, 2016 and is downtrending. It has underperformed by 64.31% the S&P500.
Terra Tech Corp (TRTC) investors sentiment decreased to 1 in 2017 Q2. It’s down -Infinity, from Infinity in 2017Q1. The ratio worsened, as 4 investment managers opened new and increased equity positions, while 0 sold and decreased their holdings in Terra Tech Corp. The investment managers in our database now own: 475,178 shares, up from 213,829 shares in 2017Q1. Also, the number of investment managers holding Terra Tech Corp in top ten equity positions was flat from 0 to 0 for the same number . Sold All: 0 Reduced: 0 Increased: 0 New Position: 4.
Terra Tech Corp., through its subsidiaries, engages in the design, marketing, and sale of hydroponic equipment with proprietary technology to create sustainable solutions for the cultivation of indoor agriculture. The company has market cap of $220.26 million. It operates through two divisions, Hydroponic Produce and Cannabis Products. It currently has negative earnings. The Hydroponic Produce segment offers produce, herbs, and floral products.
American Research & Management Co. holds 0% of its portfolio in Terra Tech Corp. for 9,500 shares. Captrust Financial Advisors owns 2,000 shares or 0% of their US portfolio. Moreover, Frontier Investment Mgmt Co has 0% invested in the